1
Clinical Trials associated with H7N9 pandemic live attenuated influenza vaccine(NIAID)A Phase I Study In Healthy Adults To Assess The Safety And Immunogenicity Of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
The purpose of this study is to evaluate the safety and immunogenicity of one dose of H7N9 pandemic live attenuated influenza vaccine (H7N9 pLAIV) followed by AS03-adjuvanted H7N9 pandemic inactivated influenza vaccine (H7N9 pIIV).
100 Clinical Results associated with H7N9 pandemic live attenuated influenza vaccine(NIAID)
100 Translational Medicine associated with H7N9 pandemic live attenuated influenza vaccine(NIAID)
100 Patents (Medical) associated with H7N9 pandemic live attenuated influenza vaccine(NIAID)
100 Deals associated with H7N9 pandemic live attenuated influenza vaccine(NIAID)